Bill > A09217

This bill modifies New York state law to protect the prescription, dispensing, and receipt of medication abortion drugs, specifically mifepristone, by ensuring that these drugs cannot be considered criminal diversion or misbranded under certain circumstances. The bill stipulates that even if a medication abortion drug is no longer approved by the FDA or does not bear its current label, it will not be deemed illegal or improperly labeled, provided two key conditions are met: first, the drug's labeling was accurate at the time of manufacture, and second, the drug is recommended for its prescribed purpose according to current World Health Organization (WHO) guidelines. This legislation effectively shields healthcare providers and patients from potential legal challenges related to medication abortion drugs by creating explicit protections in the penal and education laws. The bill aims to maintain access to medication abortion by preventing drugs from being criminalized or deemed inappropriate solely based on changes in federal approval status or labeling, while still maintaining standards of medical accuracy and adherence to professional guidelines.

Housing and Urban Affairs

https://www.nysenate.gov/legislation/bills/2025/A9217